Dr. Fleming is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-5058
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1989 - 1993
University of ManitobaClass of 1987
Certifications & Licensure
CA State Medical License 1988 - 2026
OR State Medical License 1997 - 2025
GA State Medical License 1993 - 1997
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 34 citationsMYC Promotes Bone Marrow Stem Cell Dysfunction in Fanconi Anemia.Alfredo E. Rodriguez, Kaiyang Zhang, Anniina Färkkilä, Jessica Filiatrault, Chunyu Yang
Cell Stem Cell. 2021-01-07 - 10 citationsExtrahepatic deficiency of transferrin receptor 2 is associated with increased erythropoiesis independent of iron overload.Aaron M. Wortham, Devorah C. Goldman, Juxjing Chen, William H. Fleming, An-Sheng Zhang
The Journal of Biological Chemistry. 2020-03-20 - 17 citationsLMTK3 Is Essential for Oncogenic KIT Expression in KIT-mutant GIST and MelanomaLillian R. Klug, Amber E Bannon, Nathalie Javidi-Sharifi, Ajia Town, William H. Fleming
Oncogene. 2019-02-01
Journal Articles
- LMTK3 Is Essential for Oncogenic KIT Expression in KIT-Mutant GIST and MelanomaJonathan A Fletcher, William H Fleming, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
